<DOC>
	<DOCNO>NCT02691962</DOCNO>
	<brief_summary>This study aim prospectively explore use XenMatrix™ AB Surgical Graft ventral incisional midline hernia repair patient across wound class ( `` All Comers '' ) 24 month post repair .</brief_summary>
	<brief_title>XenMatrix™ AB Surgical Graft Ventral Incisional Midline Hernias</brief_title>
	<detailed_description>This post-market , on-label study understand performance graft US .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Incisional Hernia</mesh_term>
	<criteria>Subject must willing able give write informed consent . Subject must diagnose ventral incisional midline hernia . Mesh must place retrorectus intraperitoneal plane . Subject must willing undergo open hernia repair able undergo study procedure outline protocol . The use surgical graft bridge repair . The subject 4 prior recurrence . Subject contraindication placement surgical graft . Complete removal exist mesh prior hernia repair ( affected area ) possible . The study hernia repair require single piece mesh ( include sufficient overlap beyond margin defect side ) . Subject intact permanent mesh adjacent current hernia repair . Subject peritonitis time surgery . The subject active smoker within last 2 week prior surgery . Clinically significant COPD heart failure , define marked limitation ability inability perform activity daily live . Subject chemotherapy within last 12 month , suspect place chemotherapy medication part study . Chronic steroid use ( &gt; 6 month ) immunosuppression drug . Subject 's body mass index ( BMI ) &gt; 40 kg/m2 . Subject cirrhosis , and/or ascites . Subject define collagen disorder . Known infected human immunodeficiency virus ( HIV ) . Subject clinically significant ( base solely creatinine level ) kidney disease limit ADL , hemodialysis peritoneal dialysis . Subject American Society Anesthesiology ( ASA ) Class 4 5 . Subject life expectancy &lt; 2 year time enrollment . Subject pregnant , breastfeed plan become pregnant course study . Subjects know sensitivity porcine product . Subjects allergy , history allergy hypersensitivity tetracycline ( include minocycline ) rifamycins ( include rifampin ) . Subject condition opinion Investigator would preclude use study device , preclude subject complete followup requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>